Transgenic and knockout mouse models clarify pituitary development, function and disease

Brain Pathology

Volumn 11, Issue 3, 2001, Pages 370-383

  Asa, S L ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GONADOTROPIN; GROWTH HORMONE; PHOSPHATASE; PROLACTIN RELEASING FACTOR; PROOPIOMELANOCORTIN; THYROTROPIN; TRANSCRIPTION FACTOR;

ANIMAL MODEL; BRAIN DEVELOPMENT; CARCINOGENESIS; CONFERENCE PAPER; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HOMEOBOX; HORMONE ACTION; HYPOPHYSIS DISEASE; HYPOPHYSIS FUNCTION; KNOCKOUT MOUSE; MEDICAL TECHNOLOGY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; ONCOGENE; PATHOPHYSIOLOGY; STEM CELL; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

EID: 0034985185     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2001.tb00406.x     Document Type: Conference Paper

References (74)

1. Tumor suppressor loss in pituitary tumors
2. Identification of two classes of prolactin-releasing factors in intermediate lobe tumors from transgenic mice
3. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia dopamine D2 receptor-deficient mice
4. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone
5. Growth hormone (GH) receptor-deficient mice and GH antagonist-transgenic mice provide evidence for GH autoregulation in pituitary somatotrophs
6. The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes
7. Role of growth hormone and prolactin in the control of reproduction: What are we learning from transgenic and knock-out animals?
8. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice
9. Growth hormone (GH) binding and effects of GH analogs in transgenic mice
10. Neuroendocrine abnormalities in mice lacking the receptor protein tyrosine phosphatase sigma
11. Pituitary tumors in the horse
12. DNase 1-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression
13. Transgenic mice with inducible dwarfism
14. Pituitary hyperplasia induced by ectopic expression of nerve growth factor
15. Targeted ablation of cells in the pituitary primordia of transgenic mice
16. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene
17. Targeted overexpression of galanin in lactotrophs of transgenic mice induces hyperprolactinemia and pituitary hyperplasia
18. Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice
19. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice
20. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice
21. Endocrine diseases of the dog associated with hair loss: Sertoli cell tumor of testis, hypothyroidism and canine Cushing's syndrome
22. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
23. The retinoblastoma gene in human pituitary tumors
24. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma
25. The role of hormones, growth factors and their receptors in pituitary tumorigenesis
26. Membrane-anchored expression of transforming growth factor-α in human pituitary adenoma cells
27. Kip1-deficient mice
28. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity
29. Pituitary cybernetics and neoplasia
30. Tumours of the pituitary gland
31. Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice
32. Selective pituitary resistance to thyroid hormone produced by expression of a mutant thyroid hormone receptor beta gene in the pituitary gland of transgenic mice
33. Transgenic mice that develop pituitary tumors. A model for Cushing's disease
34. Tissue-specific gene expression in the pituitary: The glycoprotein hormone alpha-subunit gene is regulated by a gonadotrope-specific protein
35. del1a/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance
36. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis
37. Effect of GnRH-associated peptide on prolactin secretion from human lactotrope adenoma cells in culture
38. Effects of an Rb mutation in the mouse
39. The human growth hormone gene is regulated by a multicomponent locus control region
40. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice
41. Implications of multiple phenotypes observed in prolactin receptor knockout mice
42. Targeted ablation of pituitary gonadotropes in transgenic mice
43. Granulomatous hypophysitis and thyroiditis with lymphocytic adrenalitis
44. Kip1
45. Gonadotrope-specific expression of the human follicle-stimulating hormone beta-subunit gene in pituitaries of transgenic mice
46. Simian virus 40 T antigen-induced gonadotroph adenomas: A model of human null cell adenomas
47. GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice
48. Tumours of the pituitary gland
49. Characterization and histologic localization of human growth hormone- variant gene expression in the placenta
50. Identification of DNA elements cooperatively activating proopiomelanocortin gene expression in the pituitary glands of transgenic mice
51. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis
52. Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene
53. Two G protein oncogenes in human endocrine tumors
54. Induced ablation of gonadotropins in transgenic mice expressing herpes simplex virus thymidine kinase under the FSH beta-subunit promoter
55. The FSH beta-subunit promoter directs the expression of Herpes simplex virus type 1 thymidine kinase to the testis of transgenic mice
56. Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas
57. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary: A possible model for human multiple endocrine neoplasia type 1
58. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
59. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes
60. Metallothionein-human GH fusion genes stimulate growth of mice
61. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: Evidence for a chromosome 13 tumor suppressor gene other than RB
62. Rat and mouse proopiomelanocortin gene sequences target tissue-specific expression to the pituitary gland but not to the hypothalamus of transgenic mice
63. Neoplasia in the parakeet. II. Transplantation of the pituitary tumor
64. Multistep control of pituitary organogenesis
65. Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation
66. G protein oncogenes in pituitary tumors
67. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice
68. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant
69. Characterization of four transplantable mammotropic pituitary tumor variants in the rat
70. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma
71. Oncogene acivation in pituitary tumors
72. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
73. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus